Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Situkulwane Lesiphephile-Safe Generations: Improving Approaches to Antiretroviral Therapy for HIV-Positive Pregnant Women

NCT01891799 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01891799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01891799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Situkulwane Lesiphephile-Safe Generations: Improving Approaches to Antiretroviral Therapy for HIV-Positive Pregnant Women
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
October 30, 2016
Enrollment
2,518 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids